Author Archive - GEN - Genetic Engineering and Biotechnology News

Home Authors Posts by Alex Philippidis

Continuing Freeze in Credit Warms Biopharma to Royalty Monetization Deals

Germany Anchors Translational Medicine Efforts with New Spending Plan and Centers

FDA Aims to Bridge Communication Gap with Drug Industry During Reviews Through PDUFA V

FDA Details Requirements for Regulatory Submissions of Genomic Biomarkers

Patent

Pfizer Edges Toward Lipitor Patent Cliff as Exclusivity Extensions Near End

Extent of Feedback on RUO/IUO In Vitro Dx Draft Guidance Means Changes Not Expected Soon

Academic Sector Leverages Open-Source Concept in Development

Big Pharma’s Open Innovation Initiatives Zoom In on Discovery

Majority Investor-Owned Small Businesses Could Rock the Boat for SBIR Participants

Accounting and Finance

Proposals in Congress to Renew SBIR Signal Changes to Program Set Up in 1982

Chilly Budget Climate All but Freezes Proposed FY ’12 Spending for NIH and CDC

FDA’s Appeal for Budget Hike Will Have to Succumb to Budget Reality

Science Agencies Feeling the Pain of Budget Cuts as Lawmakers Craft FY 2012 Budget

Prometheus and Myriad Case Outcomes Will Help Shape the Future for MDx Businesses

FDA Offers Clues to How It Will Pave the Way to Getting Biosimilars on the Market

As Obama Pitches Jobs Bill, Biobusinesses Link Growth to R&D Incentives and Early-Stage Funding

U.S. Stem Cell Firms Partnering Overseas

A Decade after 9/11, Spending Cuts Challenge Biodefense Effort Spawned by Attacks

Biopharma Venture Funds Are Stepping Up Where VC Firms Are Stepping Out

Senate Set to Enact Patent Reform Along the Lines of House Bill

< 1 … 162 163 164 165 166 167 > Page 164 of 167